湖南省2004～2005年居民糖尿病死亡状况及疾病负担研究
|
摘要
目的：
了解湖南省2004-2005年居民糖尿病死亡水平、分布特征及因糖尿病死亡造成的疾病负担,分析可能的原因及危险因素,为制定相应防制策略和措施,预防和控制居民糖尿病的死亡提供科学依据。
方法：
1、采用死因回顾性抽样调查的方法,收集湖南省2004-2005年居民死因监测资料；
2、分别计算糖尿病死亡率、总死因构成等疾病死亡水平指标和早死所致的潜在寿命损失、工作损失、潜在期望寿命损失年和早死生命损失年等疾病负担指标；
3、采用标准化率的U检验,分析比较居民糖尿病死亡分布及造成的疾病负担差异。
结果：
1、2004-2005年湖南省居民糖尿病年均死亡率7.10/10万(标化率4.88/10万),占总死因构成比1.17%(标化构成比1.18%)；男性糖尿病粗死亡率为6.06/10万(标化死亡率4.33/10万),女性糖尿病粗死亡率8.22/10万(标化死亡率5.49/10万),女性高于男性(U=2.26,
P＜0.05)；城市居民糖尿病粗死亡率为9.94/10万,标化死亡率7.09/10万,农村居民糖尿病粗死亡率为6.15/10万(标化死亡率4.24/10万),城市高于农村(U=29.69,P<0.001)；糖尿病死亡率随着年龄增高而呈现上升趋势,主要危及中老年人群,从55岁年龄组死亡率陡增,死亡专率为21.16/10万,80-岁年龄组最高,达到93.98/10万。
2、糖尿病死亡造成的潜在减寿率(PYLL率)为0.51‰,潜在工作损失率(WPYLL率)为0.35‰。男女性之间、城乡之间PYLL率和WPYLL率无差异。男性APYLL及标化APYLL分别为7.98人年、9.96人年,女性为6.65人年、6.94人年,男性高于女性；农村APYLL(8.41人年)高于城市(5.07人年)。男性AWPYLL及标化AWPYLL分别为5.63人年、7.16人年,女性为4.27人年、4.40人年,男性高于女性；AWPYLL农村(5.85人年)高于城市(3.07人年)。
3、湖南省居民因糖尿病死亡导致的早死生命损失年率(YLLs/1000)为0.97(标化率0.69),随着年龄的增长而增加,YLLs主要由50岁以上的中老年人承担,占92.25%；YLLs/1000城市高于农村。
4、湖南省居民因糖尿病死亡所致潜在期望寿命损失年(EPYLLP)为161.78人年,其中城市为141.30人年,农村为168.63人年；农村高于城市,主要危害人群为30-59岁。
结论：
1、湖南省居民糖尿病死亡率低于中国中部水平。死亡率、总死因构成比女性高于男性,城市高于农村；随着年龄增长,糖尿病死亡率和构成比增高,55岁以上人群糖尿病死亡率呈加速上升趋势。
2、湖南省居民糖尿病死亡造成的潜在寿命损失年率和潜在工作损失年率在男女性之间、城乡之间比较接近；平均潜在寿命损失年和潜在工作损失年则为男性高于女性,农村高于城市。
3、湖南省居民因糖尿病死亡造成的早死生命损失年主要集中在50岁以上的中老年人群,随着年龄的增长而不断增加；早死生命损失年率农村高于城市。
4、湖南省居民因糖尿病死亡造成的潜在期望寿命损失农村高于城市,主要集中在30-59岁,该年龄段人群应成为防制的重点。
Objective:
To understand the death levels, the characteristics of distribution, the burden of disease caused by diabetes mellitus death among Hunan residents in 2004-2005, analyze the possible causes, the risk factors, and formulate the strategy for disease control and prevention.
Methods:
1 To collect the data of death surveillance in Hunan during 2004-2005 by adopting the death cause of a sample survey methodology.
2 To calculate mortality rate, proportion of the total death, potential years of life lost (PYLL), working potential years of life lost (WPYLL), the expected years of potential life lost (EYPLL), years of life lost(YLLs) and other related indicators.
3 Using U-test to analyze and compare with the difference in population distribution of mortality, the burden of disease caused by diabetes mellitus death.
Results:
1 The mortality rates of diabetes mellitus were 7.10 per100000 during 2004-2005, which standardized 4.88 per100000, and with the proportion of contribution of 1.17% in death causes of all diseases, which standardized 1.18%. It was higher among females with the mortality rates of 6.06 per100000, which standardized 4.33 per100000 than in males with the mortality rates of 8.22 per100000, which standardized 5.49 per100000 (U=2.26, P< 0.05); it was also higher among urban with the mortality rates of 9.94 per100000, which standardized 7.09 per100000 than in rural with 6.15 per100000, which standardized 4.24 per100000 (U = 29.69, P< 0.001). The mortality rates increased with the age, and the middle and old ages are the main populations. It increased rapidly among people above 55 years, from 21.16 per 100000 in people aged 55 to 93.98 per 100000 in people aged 80, and with the proportion of contribution of 83.14% to people above 55 years.
2 The rates of potential years of life lost(PYLL) were 0.51‰, and the average of PYLL (APYLL) was 7.24 years; the rates of work potential years of life lost(WPYLL) were 0.35%o and the average of WPYLL (AWPYLL) was 4.87 years. There were no difference in the rates of PYLL and WPYLL on diabetes mellitus dearth among females and males though the APYLL and AWPYLL were lower; and so as among urban and rural.
3 The rates of years of life lost (YLLs/1000) were 0.97, which standardized 0.69. It was higher in rural than in urban and increased with the age, and the middle and old ages are the main populations with proportion of contribution of 92.25%.
4 The expected years of potential life lost (EYPLL) was 161.78 years and the main populations was 30-59 years; it was higher in rural with 168.63 years than in urban with 141.30 years.
Conclusion:
1 The mortality rates of diabetes mellitus in Hunan Province were lower than in central China. The mortality rates, and the proportion of contribution in the total causes of death were higher in women than in men, so as in urban than in rural areas; the mortality rates of diabetes mellitus were increased with ages, and accelerated in people above the age of 55.
2 There were no difference on the rates of potential years of life lost and working potential years of life lost in men and women or in urban and rural areas caused by the death of diabetes mellitus in Hunan Province; while the average potential years of life lost and working potential years of life lost were higher.
3 The years of life lost in residents caused by deaths of diabetes mellitus in Hunan Province increased with age and mainly in the elder above the age group of 50 years.
4 The expected years of potential life lost caused by diabetes mellitus deaths in Hunan Province was higher in rural areas than in urban, and mainly in group of 30 to 59 years, which should be the focus of prevention and control.
了解湖南省2004-2005年居民糖尿病死亡水平、分布特征及因糖尿病死亡造成的疾病负担,分析可能的原因及危险因素,为制定相应防制策略和措施,预防和控制居民糖尿病的死亡提供科学依据。
方法：
1、采用死因回顾性抽样调查的方法,收集湖南省2004-2005年居民死因监测资料；
2、分别计算糖尿病死亡率、总死因构成等疾病死亡水平指标和早死所致的潜在寿命损失、工作损失、潜在期望寿命损失年和早死生命损失年等疾病负担指标；
3、采用标准化率的U检验,分析比较居民糖尿病死亡分布及造成的疾病负担差异。
结果：
1、2004-2005年湖南省居民糖尿病年均死亡率7.10/10万(标化率4.88/10万),占总死因构成比1.17%(标化构成比1.18%)；男性糖尿病粗死亡率为6.06/10万(标化死亡率4.33/10万),女性糖尿病粗死亡率8.22/10万(标化死亡率5.49/10万),女性高于男性(U=2.26,
P＜0.05)；城市居民糖尿病粗死亡率为9.94/10万,标化死亡率7.09/10万,农村居民糖尿病粗死亡率为6.15/10万(标化死亡率4.24/10万),城市高于农村(U=29.69,P<0.001)；糖尿病死亡率随着年龄增高而呈现上升趋势,主要危及中老年人群,从55岁年龄组死亡率陡增,死亡专率为21.16/10万,80-岁年龄组最高,达到93.98/10万。
2、糖尿病死亡造成的潜在减寿率(PYLL率)为0.51‰,潜在工作损失率(WPYLL率)为0.35‰。男女性之间、城乡之间PYLL率和WPYLL率无差异。男性APYLL及标化APYLL分别为7.98人年、9.96人年,女性为6.65人年、6.94人年,男性高于女性；农村APYLL(8.41人年)高于城市(5.07人年)。男性AWPYLL及标化AWPYLL分别为5.63人年、7.16人年,女性为4.27人年、4.40人年,男性高于女性；AWPYLL农村(5.85人年)高于城市(3.07人年)。
3、湖南省居民因糖尿病死亡导致的早死生命损失年率(YLLs/1000)为0.97(标化率0.69),随着年龄的增长而增加,YLLs主要由50岁以上的中老年人承担,占92.25%；YLLs/1000城市高于农村。
4、湖南省居民因糖尿病死亡所致潜在期望寿命损失年(EPYLLP)为161.78人年,其中城市为141.30人年,农村为168.63人年；农村高于城市,主要危害人群为30-59岁。
结论：
1、湖南省居民糖尿病死亡率低于中国中部水平。死亡率、总死因构成比女性高于男性,城市高于农村；随着年龄增长,糖尿病死亡率和构成比增高,55岁以上人群糖尿病死亡率呈加速上升趋势。
2、湖南省居民糖尿病死亡造成的潜在寿命损失年率和潜在工作损失年率在男女性之间、城乡之间比较接近；平均潜在寿命损失年和潜在工作损失年则为男性高于女性,农村高于城市。
3、湖南省居民因糖尿病死亡造成的早死生命损失年主要集中在50岁以上的中老年人群,随着年龄的增长而不断增加；早死生命损失年率农村高于城市。
4、湖南省居民因糖尿病死亡造成的潜在期望寿命损失农村高于城市,主要集中在30-59岁,该年龄段人群应成为防制的重点。
Objective:
To understand the death levels, the characteristics of distribution, the burden of disease caused by diabetes mellitus death among Hunan residents in 2004-2005, analyze the possible causes, the risk factors, and formulate the strategy for disease control and prevention.
Methods:
1 To collect the data of death surveillance in Hunan during 2004-2005 by adopting the death cause of a sample survey methodology.
2 To calculate mortality rate, proportion of the total death, potential years of life lost (PYLL), working potential years of life lost (WPYLL), the expected years of potential life lost (EYPLL), years of life lost(YLLs) and other related indicators.
3 Using U-test to analyze and compare with the difference in population distribution of mortality, the burden of disease caused by diabetes mellitus death.
Results:
1 The mortality rates of diabetes mellitus were 7.10 per100000 during 2004-2005, which standardized 4.88 per100000, and with the proportion of contribution of 1.17% in death causes of all diseases, which standardized 1.18%. It was higher among females with the mortality rates of 6.06 per100000, which standardized 4.33 per100000 than in males with the mortality rates of 8.22 per100000, which standardized 5.49 per100000 (U=2.26, P< 0.05); it was also higher among urban with the mortality rates of 9.94 per100000, which standardized 7.09 per100000 than in rural with 6.15 per100000, which standardized 4.24 per100000 (U = 29.69, P< 0.001). The mortality rates increased with the age, and the middle and old ages are the main populations. It increased rapidly among people above 55 years, from 21.16 per 100000 in people aged 55 to 93.98 per 100000 in people aged 80, and with the proportion of contribution of 83.14% to people above 55 years.
2 The rates of potential years of life lost(PYLL) were 0.51‰, and the average of PYLL (APYLL) was 7.24 years; the rates of work potential years of life lost(WPYLL) were 0.35%o and the average of WPYLL (AWPYLL) was 4.87 years. There were no difference in the rates of PYLL and WPYLL on diabetes mellitus dearth among females and males though the APYLL and AWPYLL were lower; and so as among urban and rural.
3 The rates of years of life lost (YLLs/1000) were 0.97, which standardized 0.69. It was higher in rural than in urban and increased with the age, and the middle and old ages are the main populations with proportion of contribution of 92.25%.
4 The expected years of potential life lost (EYPLL) was 161.78 years and the main populations was 30-59 years; it was higher in rural with 168.63 years than in urban with 141.30 years.
Conclusion:
1 The mortality rates of diabetes mellitus in Hunan Province were lower than in central China. The mortality rates, and the proportion of contribution in the total causes of death were higher in women than in men, so as in urban than in rural areas; the mortality rates of diabetes mellitus were increased with ages, and accelerated in people above the age of 55.
2 There were no difference on the rates of potential years of life lost and working potential years of life lost in men and women or in urban and rural areas caused by the death of diabetes mellitus in Hunan Province; while the average potential years of life lost and working potential years of life lost were higher.
3 The years of life lost in residents caused by deaths of diabetes mellitus in Hunan Province increased with age and mainly in the elder above the age group of 50 years.
4 The expected years of potential life lost caused by diabetes mellitus deaths in Hunan Province was higher in rural areas than in urban, and mainly in group of 30 to 59 years, which should be the focus of prevention and control.
引文
[1]WHO. The World Health Report [M]. Geneva:Publication of WHO,1998,91.
[2]Gojka R, Nigel U, Peter H, et al. The Burden of Mortality Attributable to Diabetes[J]. Diabetes Care,2005; 28:2130-2135.
[3]Albert KGMM. The diagnosis and typing for diabetes mellitus [J]. Diabetes Voice,1999; 44: 35.
[4]李立明.流行病学[M].第六版,北京：人民卫生出版社,2007：407-429.
[5]International Diabetes Federation. Diabetes Atlas (third edition)[R].2007.
[6]中华医学会糖尿病学分会.2007版中国2型糖尿病防治指南[J].中华内分泌杂志,2008；24(2)：增录2a-1-2a-23.
[7]卢伟,周峰,宋桂香,等.上海市糖尿病死亡趋势APC模型分析[J].环境与职业医学,2006；23(3)：191-196.
[8]Hollenberg NK. Mortality in type 2 diabetes mellitus[J]. Journal of Hypertension 2007; 25(12): 2381-2382.
[9]Cai H, Shu XO, Gao YT, et al. A Prospective Study of Dietary Patterns and Mortality in Chinese Women[J]. Epidemiology 2007; 18:393-401.
[10]许曼音.糖尿病学[M].上海：上海科学技术出版社,2006：90-98.
[11]杨功焕,王俊芳,万霞.影响中国人群疾病死亡因素的定量分析[J].中华流行病学杂志,2005；26(12)：934-938.
[12]陈竺.全国第三次死因回顾抽样调查报告[M].北京：中国协和医科大学出版社.2008,52-121.
[13]张震巍,陈洁,唐智柳,等.中国糖尿病直接卫生费用研究[J].中国卫生资源,2007；10(3)：162-168.
[14]张永新,王梅.1980-2002年我国居民糖尿病疾病负担和变化趋势[J].中国卫生经济,2009；28(3)：46-48.
[15]http://www.who.int/healthinfo/bod/en
[16]《中国糖尿病防治指南》编写组.中国糖尿病防治指南[M].北京：北京大学医学出版社,2004：10-17.
[17]Begg SJ, Theo Vos, Barker B et al. Burden of disease and injury in Australia in the new millennium measuring health loss from disease, injuries and risk factors [R]. Public Health, 2006; 18(1):36-40.
[18]唐红梅,谢庆文,施榕.糖尿病社区干预效果评价[J].上海交通大学学报(医学版),2007；27(7)：879.
[19]刘克军,王梅.我国慢性病直接经济负担研究[J].中国卫生经济,2005；24(10)：77-80.
[20]王声湧.死因分析与评价方法的进展[J].中华流行病学杂志,1996；17(4)：239-242.
[21]胡建平,陈育德,毛嘉文,等.导致早死疾病的潜在期望寿命损失测量[J].中国卫生统计,1999；16(1)：24-27.
[22]杨功焕.中国人群死亡及其危险因素流行水平、趋势和分布[M].中国协和医科大学出版社.2005,322.
[23]时黎,黄钧裕,付笑冰,等.2003年广东省居民呼吸系统疾病死亡的疾病负担研究[J].广州医学院学报,2006；34(2)：17-19.
[24]洪天配.糖尿病诊断与防治工作最新进展[J].中国实用内科杂志,2007；27(13)：1052-1053.
[25]童钟杭.糖尿病与心血管病[M].心脑血管病防治,2003；3：1-2.
[26]Verlato G, Zoppini G, Bonora E, et al. Mortality for site-specific malignancies in type 2 diabetic patients from Veroma[J]. Diabetes Care,2003; 26:1047-1051.
[27]Perreault L, Ma Y, Dagogo-Jack S, et al. Sex Differences in Diabetes Risk and the Effect of Intensive Lifestyle Modification in the Diabetes Prevention Program[J]. Diabetes Care, 2008;31(7):1416-1421.
[28]罗俊,孙惠玲,段纪俊,等.1975--2006年武汉市居民糖尿病死亡率分析及预测[J].中国慢性病预防与控制,2008；16(4)：343-346.
[29]曹丽,王丽娜,张敬一,等.河北省国家疾病监测点糖尿病病死率及减寿分析[J].河北医药,2009；31(2)：227-229.
[30]格鹏飞,任晓岚,张丑吉,等.2007年甘肃省疾病监测点死因谱及潜在减寿年数构成特征[J].中国初级卫生保健,2009；23(10)：53-54.
[31]钱永刚.内蒙古自治区疾病监测点2004-2005年居民主要死因及减寿分析[J].中国卫生统计,2009；26(3)：276-278.
[32]韦再华,谢学勤,卫建敏.北京市人口老龄化及危险因素改变对糖尿病死亡率的影响[J].中华预防医学杂志,2005；39(4)：277-279.
[33]底秀娟,轩水丽,郭万申,等.河南省居民死亡模式变化趋势分析[J].中国公共卫生,2009；25(8)：903-904.
[34]Caspersent JC, Fulton J. Epidemiology of Walking and Type 2 Diabetes[J]. Official Journal of the American College of Sports Medicine2008,s519-s528. http://www.acsm-msse.org.
[35]徐春生,余灿清,李立明.老年糖尿病[J].中国全科医学,2007；10(12)：1036-1039.
[36]迟家敏.实用糖尿病学[M].第3版,北京：人民卫生出版社,2009：1-9.
[37]王陇德.中国居民营养与健康状况调查报告之一[M].北京：人民卫生出版社,2002：75.
[38]Flack JM, Peters R, Shafi T, et al. Prevention of hypertension and its complications; theoretical basis and guidelines for treatment[J]. J Am Soc Nephrol.2003; 14:92-98.
[39]孔丹莉,张广思,潘海燕,等.2型糖尿病患者生存质量影响因素分析[J].中国公共卫生,2007；23(6)：712.
[40]彭燕,李静.老年糖尿病的死亡原因及其相关危险因素分析[J].实用糖尿病杂志,2007；3(2)：44-45.
[41]Palmas W, Pickering TG, Teresi J, et al. Ambulatory Blood Pressure Monitoring and All-Cause Mortality in Elderly People With Diabetes Mellitus[J]. Hypertension.2009; 53: 120-127.
[42]Jee SH, Ohrr H, Sull JW, et al. Fasting serum glucose lever and cancer risk in Korean men and women [J]. JAMA,2005,293:194-202.
[43]IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes:recommendations for standard, comprehensive, and minimal care [J]. Diabetic Medicine,2006,23:579-593.
[44]Espelt A, Borrell C, Roskam AJ, et al. Socioeconomic inequalities in diabetes mellitus across Europe at the beginning of the 21st century[J]. Diabetologia.2008,51:1971-1979.
[45]James K, Sower MD, Melvin A, et al. Diabetes and Cardiovascular Disease[J]. Diabetes Care,1999,22(suppl 3):C14.
[46]胡善联.疾病负担的研究(上)[J].卫生经济研究,2005；(5)：22-27.
[47]IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes:recommendations for standard, comprehensive, and minimal care [J]. Diabetic Medicine,2006; 23:579-593.
[48]巩秋红,李光伟.2005北京国际糖尿病预防高层论坛纪要[J].中华内分泌代谢杂志,2006；22：94-95.
[1]WHO. The World Health Report [M]. Geneva:Publication of WHO,1998,91.
[2]Gojka R, Nigel U, Peter H, et al. The Burden of Mortality Attributable to Diabetes[J]. Diabetes Care,2005,28:2130-2135.
[3]Albert KGMM. The diagnosis and typing for diabetes mellitus [J]. Diabetes Voice, 1999,44:35.
[4]李立明.流行病学[M].第六版,北京：人民卫生出版社,2007：407-429.
[5]International Diabetes Federation. Diabetes Atlas (third edition)[R].2007.
[6]中华医学会糖尿病学分会.2007版中国2型糖尿病防治指南[J].中华内分泌杂志,2008；24(2)：增录2a-1-2a-23.
[7]洪天配.糖尿病诊断与防治工作最新进展[J].中国实用内科杂志,2007,27(13)：1052-1053.
[8]Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population:National Health And Nutrition Examination Survey 1999-2002[J]. Diabetes Care,2006,29(6):1263-1268.
[9]People's Daily Online. China has annual increase of 1.2 million diabetes patients[EB/OL].http://english.peopledaily.com.cn/200011/14/eng20001114_551 62.html,2008-02-29.
[10]包玉倩.中华医学会糖尿病分会第十二次全国学术会议纪要[J].中华内分泌杂志,2008；24(6)：695-699.
[11]迟家敏.实用糖尿病学[M].第3版,北京：人民卫生出版社,2009：1-9.
[12]向红丁,吴纬,刘灿群,等.1996年全国糖尿病流行病学特点基线调查报告[J].中国糖尿病杂志；1998,6：131-133.
[13]张坚,王春荣,付萍,等.2002年中国城市居民糖尿病流行状况分析[J].中华预防医学杂志；2007,41(1)：4-7.
[14]Karvonen M, Pitkaniemi J, Tuomilehto J. The onset age of type1 diabetes in Finish children has become younger:the Finish Childhood Diabetes Registry Group[J]. Diabetes Care 1999; 22:1066-1070.
[15]M(?)lbak AG, Chritau B, Marnar B, et al. Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark[J]. Diabet Med 1994; 11: 650-655.
[16]全国糖尿病研究协作组调查研究组.全国14省市30万人口中糖尿病调查报告[J].中华内科杂志,1981,20(11)：678-683.
[17]李立明,饶克勤,孔灵芝,等.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7)：478-484.
[18]龙慧英,李志红,李晓萍.青海省糖尿病流行病学现患调查[J].现代预防医学,2005；132(19)：1145-1146.
[19]孙纪新,朱俊卿,张建新,等.河北省成年居民糖尿病患病及防治状况调查[J].中国公共卫生,2006；22(7)：801-803.
[20]刘军,唐振柱,陈兴乐,等.2002年广西城乡成年居民糖尿病流行病学调查[J].华中科技大学学报(医学版),2006；35(5)：648-652.
[21]潘长玉,主译.Joslin糖尿病学[M].第14版,北京：人民卫生出版社,2007：15-16.
[22]国家“九五”公关计划糖尿病研究协作组.中国12地区中老年人糖尿病患病率调查[J].中华内分泌代谢杂志,2002,18(4)：280-284.
[23]全国糖尿病防治协作组.1994年中国糖尿病及其危险因素[J].中华内科杂志,1997,63(6)：384.
[24]Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990-1998[J]. Diabetes Care 2000; 23:1278-1283.
[25]杨功焕,王俊芳,万霞.影响中国人群疾病死亡因素的定量分析[J].中华流行病学杂志,2005；26(12)：934-938.
[26]陈竺.全国第三次死因回顾抽样调查报告[M].中国协和医科大学出版社. 2008.52-121.
[27]James K, Sower MD, Melvin A, et al. Diabetes and Cardiovascular Disease[J]. Diabetes Care,1999,22 (suppl 3):C14.
[28]Espelt A, Borrell C, Roskam AJ, et al. Socioeconomic inequalities in diabetes mellitus across Europe at the beginning of the 21st century [J]. Diabetologia. 2008,51:1971-1979.
[29]许曼英.糖尿病学[M].上海：上海科学技术出版社,2006：90-98.
[30]WHO Ad Hoc Diabetes Reporting Group. Global estimates for prevalence of diabetes mellitus and IGT in adults[J]. Diabetes Care,1997,16:157-177.
[31]罗俊,孙惠玲,段纪俊,等.1975—2006年武汉市居民糖尿病死亡率分析及预测[J].中国慢性病预防与控制,2008；16(4)：343-346.
[32]孙凯峰,杨妍,王芙蓉.1995-2004年沈阳市城区居民糖尿病死亡分析[J].中国卫生统计,2006；23(4)：348-349.
[33]李锐,王振果.1990-1999年我国居民糖尿病死亡率分析及预测[J].中国慢性病预防与控制,2002；10(5)：216-218.
[34]卢伟,周峰,宋桂香,等.上海市糖尿病死亡趋势APC模型分析[J].环境与职业医学,2006；23(3)：191-196.
[35]《中国糖尿病防治指南》编写组.中国糖尿病防治指南[M].北京：北京大学医学出版社,2004：10-17.
[36]张震巍,陈洁,唐智柳,等.中国糖尿病直接卫生费用研究[J].中国卫生资源,2007,10(3)：162-168.
[37]张永新,王梅.1980-2002年我国居民糖尿病疾病负担和变化趋势[J].中国卫生经济,2009；28(3)：46-48.
[38]http://www.who.int/healthinfo/bod/en
[39]Begg SJ, Theo Vos, Barker B et al. Burden of disease and injury in Australia in the new millennium measuring health loss from disease, injuries and risk factors [R]. Public Health,2006,18(1):36-40.
[40]唐红梅,谢庆文,施榕.糖尿病社区干预效果评价[J].上海交通大学学报(医学版),2007；27(7)：879.
[41]刘克军,王梅.我国慢性病直接经济负担研究[J].中国卫生经济,2005；24(10)：77-80.
[42]胡善联,刘国恩,许樟荣,等.我国糖尿病流行病学和疾病经济负担研究现状[J].中国卫生经济,2008；27(8)：5-8.
[43]李娟,于保荣,孟庆跃,等.山东、宁夏农村居民5种常见慢性病的疾病经 济负担分析[J].中国卫生经济,2008；27(3)：63-65.
[44]Bonneux L. How to measure the burden of mortality[J]. Journal of Epidemiology and Community Health,2002,56 (2):1282-131.
[45]CDC. Year of potential life lost before ages 65 and 85, United States, 1989-1990[J]. MMWR,1992,18:313.
[46]McKenna MT, Michaud CM, Murray CJ, et al. Assessing the burden of disease in the united states using disability adjusted life years[J]. Am J Prev Med,2005,28 (5):415.
[47]王兰英.我国Ⅱ型糖尿病的流行病学及危险因素研究[J].中国医药导报,2007；4(12)：4.
[48]张茂熔,杨昭,沈岚,等.昆明市农村地区人群糖尿病患病现状及其危险因素分析[J].中国初级卫生保健,2009；23(3)：50-52.
[49]Colditz GA, Willet WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in women[J]. Ann Intern Med 1995; 122:481-486.
[50]杨泽,郑宏,史晓红,等.超重、肥胖及其与糖尿病的患病风险分析[J].中华内分泌代谢杂志,2003；19(3)：177-180.
[51]曾平,张毅,张铁梅,等.代谢综合征各组分及其聚集与2型糖尿病的相关性分析[J].中国糖尿病杂志,2007；15(6)：327-329.
[52]Folsom AR, Kushi LH, Hong CP. Physical activity and incident diabetes mellitus in postmenopausal women[J]. Am J Public Health 2000; 90:134-138.
[53]陈黎亚,李志远.糖尿病与膳食因素及其他相关因素的研究[J].河南预防医学杂志,2004；15(3)：140.
[54]王艳,黄久仪,曹奕丰,等.上海农村社区中老年人群2型糖尿病危险因素的调查：巢式病例-对照[J].中国组织工程研究与临床康复,2007；11(52)：433-436.
[55]邢惠莉,金杰,秦利,等.上海宝山地区人群糖尿病调查及其危险因素分析[J].上海交通大学学报(医学版),2007；27(10)：1268-1270.
[56]杨泽.中国中老年人糖尿病和糖耐量异常的流行病学研究[J].中华流行病学杂志,2003；24：410-412.
[57]International Diabetes Federation. The United Nations passed the resolution on diabetes [EB/OL]. (2006-12-20) [2006-12-22]. http://www. idf. org.
[58]Jee SH, Ohrr H, Sull JW, et al. Fasting serum glucose lever and cancer risk in Korean men and women [J]. JAMA,2005,293:194-202.
[59]IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care [J]. Diabetic Medicine,2006; 23:579-593.
[60]巩秋红,李光伟.2005北京国际糖尿病预防高层论坛纪要[J].中华内分泌代谢杂志,2006；22：94-95.
[61]Verlato G, Zoppini G, Bonora E, et al. Mortality for site-specific malignancies in type 2 diabetic patients from Veroma[J]. Diabetes Care,2003,26:1047-1051.
[62]Perreault L, Ma Y, Dagogo-Jack S, et al. Sex Differences in Diabetes Risk and the Effect of Intensive Lifestyle Modification in the Diabetes Prevention Program[J]. Diabetes Care,2008; 31(7):1416-1421.
[63]Hollenberg NK. Mortality in type 2 diabetes mellitus[J]. Journal of Hypertension 2007,25(12):2381-2382.
[64]Cai H, Shu XO, Gao YT, et al. A Prospective Study of Dietary Patterns and Mortality in Chinese Women[J]. Epidemiology 2007; 18:393-401.
[65]Caspersent JC, Fulton J. Epidemiology of Walking and Type 2 Diabetes[J]. Official Journal of the American College of Sports Medicine2008,s519-s528. http://www.acsm-msse.org.
[66]Palmas W, Pickering TG, Teresi J, et al. Ambulatory Blood Pressure Monitoring and All-Cause Mortality in Elderly People With Diabetes Mellitus[J]. Hypertension.2009; 53:120-127.
[67]美国糖尿病学会(ADF)1糖尿病诊疗标准(一)[J].国外医学内分泌学分册,2005;25：436-437.
[68]Rizvi AA. Management of Diabetes in Older Adults[J]. Am J Med Sci 2007; 333(1):35-47.
[69]Palmas W, Pickering TG, Teresi J, et al. Ambulatory Blood Pressure Monitoring and All-Cause Mortality in Elderly People With Diabetes Mellitus[J]. Hypertension.2009; 53:120-127.
[2]Gojka R, Nigel U, Peter H, et al. The Burden of Mortality Attributable to Diabetes[J]. Diabetes Care,2005; 28:2130-2135.
[3]Albert KGMM. The diagnosis and typing for diabetes mellitus [J]. Diabetes Voice,1999; 44: 35.
[4]李立明.流行病学[M].第六版,北京：人民卫生出版社,2007：407-429.
[5]International Diabetes Federation. Diabetes Atlas (third edition)[R].2007.
[6]中华医学会糖尿病学分会.2007版中国2型糖尿病防治指南[J].中华内分泌杂志,2008；24(2)：增录2a-1-2a-23.
[7]卢伟,周峰,宋桂香,等.上海市糖尿病死亡趋势APC模型分析[J].环境与职业医学,2006；23(3)：191-196.
[8]Hollenberg NK. Mortality in type 2 diabetes mellitus[J]. Journal of Hypertension 2007; 25(12): 2381-2382.
[9]Cai H, Shu XO, Gao YT, et al. A Prospective Study of Dietary Patterns and Mortality in Chinese Women[J]. Epidemiology 2007; 18:393-401.
[10]许曼音.糖尿病学[M].上海：上海科学技术出版社,2006：90-98.
[11]杨功焕,王俊芳,万霞.影响中国人群疾病死亡因素的定量分析[J].中华流行病学杂志,2005；26(12)：934-938.
[12]陈竺.全国第三次死因回顾抽样调查报告[M].北京：中国协和医科大学出版社.2008,52-121.
[13]张震巍,陈洁,唐智柳,等.中国糖尿病直接卫生费用研究[J].中国卫生资源,2007；10(3)：162-168.
[14]张永新,王梅.1980-2002年我国居民糖尿病疾病负担和变化趋势[J].中国卫生经济,2009；28(3)：46-48.
[15]http://www.who.int/healthinfo/bod/en
[16]《中国糖尿病防治指南》编写组.中国糖尿病防治指南[M].北京：北京大学医学出版社,2004：10-17.
[17]Begg SJ, Theo Vos, Barker B et al. Burden of disease and injury in Australia in the new millennium measuring health loss from disease, injuries and risk factors [R]. Public Health, 2006; 18(1):36-40.
[18]唐红梅,谢庆文,施榕.糖尿病社区干预效果评价[J].上海交通大学学报(医学版),2007；27(7)：879.
[19]刘克军,王梅.我国慢性病直接经济负担研究[J].中国卫生经济,2005；24(10)：77-80.
[20]王声湧.死因分析与评价方法的进展[J].中华流行病学杂志,1996；17(4)：239-242.
[21]胡建平,陈育德,毛嘉文,等.导致早死疾病的潜在期望寿命损失测量[J].中国卫生统计,1999；16(1)：24-27.
[22]杨功焕.中国人群死亡及其危险因素流行水平、趋势和分布[M].中国协和医科大学出版社.2005,322.
[23]时黎,黄钧裕,付笑冰,等.2003年广东省居民呼吸系统疾病死亡的疾病负担研究[J].广州医学院学报,2006；34(2)：17-19.
[24]洪天配.糖尿病诊断与防治工作最新进展[J].中国实用内科杂志,2007；27(13)：1052-1053.
[25]童钟杭.糖尿病与心血管病[M].心脑血管病防治,2003；3：1-2.
[26]Verlato G, Zoppini G, Bonora E, et al. Mortality for site-specific malignancies in type 2 diabetic patients from Veroma[J]. Diabetes Care,2003; 26:1047-1051.
[27]Perreault L, Ma Y, Dagogo-Jack S, et al. Sex Differences in Diabetes Risk and the Effect of Intensive Lifestyle Modification in the Diabetes Prevention Program[J]. Diabetes Care, 2008;31(7):1416-1421.
[28]罗俊,孙惠玲,段纪俊,等.1975--2006年武汉市居民糖尿病死亡率分析及预测[J].中国慢性病预防与控制,2008；16(4)：343-346.
[29]曹丽,王丽娜,张敬一,等.河北省国家疾病监测点糖尿病病死率及减寿分析[J].河北医药,2009；31(2)：227-229.
[30]格鹏飞,任晓岚,张丑吉,等.2007年甘肃省疾病监测点死因谱及潜在减寿年数构成特征[J].中国初级卫生保健,2009；23(10)：53-54.
[31]钱永刚.内蒙古自治区疾病监测点2004-2005年居民主要死因及减寿分析[J].中国卫生统计,2009；26(3)：276-278.
[32]韦再华,谢学勤,卫建敏.北京市人口老龄化及危险因素改变对糖尿病死亡率的影响[J].中华预防医学杂志,2005；39(4)：277-279.
[33]底秀娟,轩水丽,郭万申,等.河南省居民死亡模式变化趋势分析[J].中国公共卫生,2009；25(8)：903-904.
[34]Caspersent JC, Fulton J. Epidemiology of Walking and Type 2 Diabetes[J]. Official Journal of the American College of Sports Medicine2008,s519-s528. http://www.acsm-msse.org.
[35]徐春生,余灿清,李立明.老年糖尿病[J].中国全科医学,2007；10(12)：1036-1039.
[36]迟家敏.实用糖尿病学[M].第3版,北京：人民卫生出版社,2009：1-9.
[37]王陇德.中国居民营养与健康状况调查报告之一[M].北京：人民卫生出版社,2002：75.
[38]Flack JM, Peters R, Shafi T, et al. Prevention of hypertension and its complications; theoretical basis and guidelines for treatment[J]. J Am Soc Nephrol.2003; 14:92-98.
[39]孔丹莉,张广思,潘海燕,等.2型糖尿病患者生存质量影响因素分析[J].中国公共卫生,2007；23(6)：712.
[40]彭燕,李静.老年糖尿病的死亡原因及其相关危险因素分析[J].实用糖尿病杂志,2007；3(2)：44-45.
[41]Palmas W, Pickering TG, Teresi J, et al. Ambulatory Blood Pressure Monitoring and All-Cause Mortality in Elderly People With Diabetes Mellitus[J]. Hypertension.2009; 53: 120-127.
[42]Jee SH, Ohrr H, Sull JW, et al. Fasting serum glucose lever and cancer risk in Korean men and women [J]. JAMA,2005,293:194-202.
[43]IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes:recommendations for standard, comprehensive, and minimal care [J]. Diabetic Medicine,2006,23:579-593.
[44]Espelt A, Borrell C, Roskam AJ, et al. Socioeconomic inequalities in diabetes mellitus across Europe at the beginning of the 21st century[J]. Diabetologia.2008,51:1971-1979.
[45]James K, Sower MD, Melvin A, et al. Diabetes and Cardiovascular Disease[J]. Diabetes Care,1999,22(suppl 3):C14.
[46]胡善联.疾病负担的研究(上)[J].卫生经济研究,2005；(5)：22-27.
[47]IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes:recommendations for standard, comprehensive, and minimal care [J]. Diabetic Medicine,2006; 23:579-593.
[48]巩秋红,李光伟.2005北京国际糖尿病预防高层论坛纪要[J].中华内分泌代谢杂志,2006；22：94-95.
[1]WHO. The World Health Report [M]. Geneva:Publication of WHO,1998,91.
[2]Gojka R, Nigel U, Peter H, et al. The Burden of Mortality Attributable to Diabetes[J]. Diabetes Care,2005,28:2130-2135.
[3]Albert KGMM. The diagnosis and typing for diabetes mellitus [J]. Diabetes Voice, 1999,44:35.
[4]李立明.流行病学[M].第六版,北京：人民卫生出版社,2007：407-429.
[5]International Diabetes Federation. Diabetes Atlas (third edition)[R].2007.
[6]中华医学会糖尿病学分会.2007版中国2型糖尿病防治指南[J].中华内分泌杂志,2008；24(2)：增录2a-1-2a-23.
[7]洪天配.糖尿病诊断与防治工作最新进展[J].中国实用内科杂志,2007,27(13)：1052-1053.
[8]Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population:National Health And Nutrition Examination Survey 1999-2002[J]. Diabetes Care,2006,29(6):1263-1268.
[9]People's Daily Online. China has annual increase of 1.2 million diabetes patients[EB/OL].http://english.peopledaily.com.cn/200011/14/eng20001114_551 62.html,2008-02-29.
[10]包玉倩.中华医学会糖尿病分会第十二次全国学术会议纪要[J].中华内分泌杂志,2008；24(6)：695-699.
[11]迟家敏.实用糖尿病学[M].第3版,北京：人民卫生出版社,2009：1-9.
[12]向红丁,吴纬,刘灿群,等.1996年全国糖尿病流行病学特点基线调查报告[J].中国糖尿病杂志；1998,6：131-133.
[13]张坚,王春荣,付萍,等.2002年中国城市居民糖尿病流行状况分析[J].中华预防医学杂志；2007,41(1)：4-7.
[14]Karvonen M, Pitkaniemi J, Tuomilehto J. The onset age of type1 diabetes in Finish children has become younger:the Finish Childhood Diabetes Registry Group[J]. Diabetes Care 1999; 22:1066-1070.
[15]M(?)lbak AG, Chritau B, Marnar B, et al. Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark[J]. Diabet Med 1994; 11: 650-655.
[16]全国糖尿病研究协作组调查研究组.全国14省市30万人口中糖尿病调查报告[J].中华内科杂志,1981,20(11)：678-683.
[17]李立明,饶克勤,孔灵芝,等.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7)：478-484.
[18]龙慧英,李志红,李晓萍.青海省糖尿病流行病学现患调查[J].现代预防医学,2005；132(19)：1145-1146.
[19]孙纪新,朱俊卿,张建新,等.河北省成年居民糖尿病患病及防治状况调查[J].中国公共卫生,2006；22(7)：801-803.
[20]刘军,唐振柱,陈兴乐,等.2002年广西城乡成年居民糖尿病流行病学调查[J].华中科技大学学报(医学版),2006；35(5)：648-652.
[21]潘长玉,主译.Joslin糖尿病学[M].第14版,北京：人民卫生出版社,2007：15-16.
[22]国家“九五”公关计划糖尿病研究协作组.中国12地区中老年人糖尿病患病率调查[J].中华内分泌代谢杂志,2002,18(4)：280-284.
[23]全国糖尿病防治协作组.1994年中国糖尿病及其危险因素[J].中华内科杂志,1997,63(6)：384.
[24]Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990-1998[J]. Diabetes Care 2000; 23:1278-1283.
[25]杨功焕,王俊芳,万霞.影响中国人群疾病死亡因素的定量分析[J].中华流行病学杂志,2005；26(12)：934-938.
[26]陈竺.全国第三次死因回顾抽样调查报告[M].中国协和医科大学出版社. 2008.52-121.
[27]James K, Sower MD, Melvin A, et al. Diabetes and Cardiovascular Disease[J]. Diabetes Care,1999,22 (suppl 3):C14.
[28]Espelt A, Borrell C, Roskam AJ, et al. Socioeconomic inequalities in diabetes mellitus across Europe at the beginning of the 21st century [J]. Diabetologia. 2008,51:1971-1979.
[29]许曼英.糖尿病学[M].上海：上海科学技术出版社,2006：90-98.
[30]WHO Ad Hoc Diabetes Reporting Group. Global estimates for prevalence of diabetes mellitus and IGT in adults[J]. Diabetes Care,1997,16:157-177.
[31]罗俊,孙惠玲,段纪俊,等.1975—2006年武汉市居民糖尿病死亡率分析及预测[J].中国慢性病预防与控制,2008；16(4)：343-346.
[32]孙凯峰,杨妍,王芙蓉.1995-2004年沈阳市城区居民糖尿病死亡分析[J].中国卫生统计,2006；23(4)：348-349.
[33]李锐,王振果.1990-1999年我国居民糖尿病死亡率分析及预测[J].中国慢性病预防与控制,2002；10(5)：216-218.
[34]卢伟,周峰,宋桂香,等.上海市糖尿病死亡趋势APC模型分析[J].环境与职业医学,2006；23(3)：191-196.
[35]《中国糖尿病防治指南》编写组.中国糖尿病防治指南[M].北京：北京大学医学出版社,2004：10-17.
[36]张震巍,陈洁,唐智柳,等.中国糖尿病直接卫生费用研究[J].中国卫生资源,2007,10(3)：162-168.
[37]张永新,王梅.1980-2002年我国居民糖尿病疾病负担和变化趋势[J].中国卫生经济,2009；28(3)：46-48.
[38]http://www.who.int/healthinfo/bod/en
[39]Begg SJ, Theo Vos, Barker B et al. Burden of disease and injury in Australia in the new millennium measuring health loss from disease, injuries and risk factors [R]. Public Health,2006,18(1):36-40.
[40]唐红梅,谢庆文,施榕.糖尿病社区干预效果评价[J].上海交通大学学报(医学版),2007；27(7)：879.
[41]刘克军,王梅.我国慢性病直接经济负担研究[J].中国卫生经济,2005；24(10)：77-80.
[42]胡善联,刘国恩,许樟荣,等.我国糖尿病流行病学和疾病经济负担研究现状[J].中国卫生经济,2008；27(8)：5-8.
[43]李娟,于保荣,孟庆跃,等.山东、宁夏农村居民5种常见慢性病的疾病经 济负担分析[J].中国卫生经济,2008；27(3)：63-65.
[44]Bonneux L. How to measure the burden of mortality[J]. Journal of Epidemiology and Community Health,2002,56 (2):1282-131.
[45]CDC. Year of potential life lost before ages 65 and 85, United States, 1989-1990[J]. MMWR,1992,18:313.
[46]McKenna MT, Michaud CM, Murray CJ, et al. Assessing the burden of disease in the united states using disability adjusted life years[J]. Am J Prev Med,2005,28 (5):415.
[47]王兰英.我国Ⅱ型糖尿病的流行病学及危险因素研究[J].中国医药导报,2007；4(12)：4.
[48]张茂熔,杨昭,沈岚,等.昆明市农村地区人群糖尿病患病现状及其危险因素分析[J].中国初级卫生保健,2009；23(3)：50-52.
[49]Colditz GA, Willet WC, Rotnitzky A, et al. Weight gain as a risk factor for clinical diabetes mellitus in women[J]. Ann Intern Med 1995; 122:481-486.
[50]杨泽,郑宏,史晓红,等.超重、肥胖及其与糖尿病的患病风险分析[J].中华内分泌代谢杂志,2003；19(3)：177-180.
[51]曾平,张毅,张铁梅,等.代谢综合征各组分及其聚集与2型糖尿病的相关性分析[J].中国糖尿病杂志,2007；15(6)：327-329.
[52]Folsom AR, Kushi LH, Hong CP. Physical activity and incident diabetes mellitus in postmenopausal women[J]. Am J Public Health 2000; 90:134-138.
[53]陈黎亚,李志远.糖尿病与膳食因素及其他相关因素的研究[J].河南预防医学杂志,2004；15(3)：140.
[54]王艳,黄久仪,曹奕丰,等.上海农村社区中老年人群2型糖尿病危险因素的调查：巢式病例-对照[J].中国组织工程研究与临床康复,2007；11(52)：433-436.
[55]邢惠莉,金杰,秦利,等.上海宝山地区人群糖尿病调查及其危险因素分析[J].上海交通大学学报(医学版),2007；27(10)：1268-1270.
[56]杨泽.中国中老年人糖尿病和糖耐量异常的流行病学研究[J].中华流行病学杂志,2003；24：410-412.
[57]International Diabetes Federation. The United Nations passed the resolution on diabetes [EB/OL]. (2006-12-20) [2006-12-22]. http://www. idf. org.
[58]Jee SH, Ohrr H, Sull JW, et al. Fasting serum glucose lever and cancer risk in Korean men and women [J]. JAMA,2005,293:194-202.
[59]IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care [J]. Diabetic Medicine,2006; 23:579-593.
[60]巩秋红,李光伟.2005北京国际糖尿病预防高层论坛纪要[J].中华内分泌代谢杂志,2006；22：94-95.
[61]Verlato G, Zoppini G, Bonora E, et al. Mortality for site-specific malignancies in type 2 diabetic patients from Veroma[J]. Diabetes Care,2003,26:1047-1051.
[62]Perreault L, Ma Y, Dagogo-Jack S, et al. Sex Differences in Diabetes Risk and the Effect of Intensive Lifestyle Modification in the Diabetes Prevention Program[J]. Diabetes Care,2008; 31(7):1416-1421.
[63]Hollenberg NK. Mortality in type 2 diabetes mellitus[J]. Journal of Hypertension 2007,25(12):2381-2382.
[64]Cai H, Shu XO, Gao YT, et al. A Prospective Study of Dietary Patterns and Mortality in Chinese Women[J]. Epidemiology 2007; 18:393-401.
[65]Caspersent JC, Fulton J. Epidemiology of Walking and Type 2 Diabetes[J]. Official Journal of the American College of Sports Medicine2008,s519-s528. http://www.acsm-msse.org.
[66]Palmas W, Pickering TG, Teresi J, et al. Ambulatory Blood Pressure Monitoring and All-Cause Mortality in Elderly People With Diabetes Mellitus[J]. Hypertension.2009; 53:120-127.
[67]美国糖尿病学会(ADF)1糖尿病诊疗标准(一)[J].国外医学内分泌学分册,2005;25：436-437.
[68]Rizvi AA. Management of Diabetes in Older Adults[J]. Am J Med Sci 2007; 333(1):35-47.
[69]Palmas W, Pickering TG, Teresi J, et al. Ambulatory Blood Pressure Monitoring and All-Cause Mortality in Elderly People With Diabetes Mellitus[J]. Hypertension.2009; 53:120-127.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |